Spero Therapeutics, Inc. (SPRO)
NASDAQ·Healthcare·Biotechnology
$1.12
+4.21%
Mkt Cap $64.06M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.12
+4.21%
Mkt Cap $64.06M
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —